-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Etrasimod in Crohn’s Disease (Regional Enteritis)
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Etrasimod in Crohn's Disease (Regional Enteritis) Drug Details: Etrasimod (Velsipity) is an immunomodulatory agent. It is...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Etrasimod in Alopecia Areata
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Etrasimod in Alopecia Areata Drug Details: Etrasimod (Velsipity) is an immunomodulatory agent. It is formulated as...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Etrasimod in Eosinophilic Esophagitis
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Etrasimod in Eosinophilic Esophagitis Drug Details: Etrasimod (Velsipity) is an immunomodulatory agent. It is formulated as...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Etrasimod in Atopic Dermatitis (Atopic Eczema)
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Etrasimod in Atopic Dermatitis (Atopic Eczema) Drug Details: Etrasimod (Velsipity) is an immunomodulatory agent. It is...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Etrasimod in Crohn’s Disease (Regional Enteritis)
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.Etrasimod in Crohn's Disease (Regional Enteritis) Drug Details:Etrasimod (APD-334) is under development for the treatment of...
-
Product Insights
![]()
Net Present Value Model: Etrasimod
Overview Evaluating the value of drugs is a complicated practice and requires a deep knowledge of the drug itself, the market currently and in the future, knowledge of cash inflows and outflows and the potential success rates for each stage of drug development. GlobalData has done all of this work for you, leveraging its gold standard Drugs Intelligence database to create high-value NPV models for purchase on a drug-by-drug basis. Drug Operating Profit Model Etrasimod Drug Details Etrasimod (APD-334) is...
-
Product Insights
![]()
Likelihood of Approval and Phase Transition Success Rate Model – etrasimod
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry etrasimod Drug Details Etrasimod (APD-334) is under development for the treatment of moderately to...
-
Company Insights
![]()
OpenText – Enterprise Tech Ecosystem Series
OpenText operates a Global Partner Program framework comprising five distinct programs: referral, reseller, services, technology, and support. It leverages the framework to provide a comprehensive ecosystem of digital transformation business solutions. OpenText has undertaken various initiatives to build a digitally advanced business through in-house product developments and acquisitions. OpenText is a leading provider of cloud-based digital transformation solutions and aims to further strengthen its Cloud First Strategy. The company is leveraging cloud technology to enhance its expertise in EIM solutions....
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.